SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347564
Filing Date
2012-08-09
Accepted
2012-08-09 16:16:05
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d351654d10q.htm 10-Q 492527
2 EX-31.1 d351654dex311.htm EX-31.1 9804
3 EX-31.2 d351654dex312.htm EX-31.2 9952
4 EX-32.1 d351654dex321.htm EX-32.1 5082
11 GRAPHIC g351654p1.jpg GRAPHIC 1197
  Complete submission text file 0001193125-12-347564.txt   3364032

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20120630.xml EX-101.INS 467216
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20120630.xsd EX-101.SCH 33063
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20120630_cal.xml EX-101.CAL 39935
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20120630_def.xml EX-101.DEF 97568
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20120630_lab.xml EX-101.LAB 251236
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20120630_pre.xml EX-101.PRE 171391
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 121020574
SIC: 2834 Pharmaceutical Preparations